Published on 25 January 2019
Body text 1
Benlahfid M, Traboulsi W, Sergent F, Benharouga M, Elhattabi K, Erguibi D, Karkouri M, Elattar H, Fadil A, Fahmi Y, Aboussaouira T and Alfaidy N
Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis.
Cancer Biomarkers, 2018, 21(2): 345-354
Reynaud D, Sergent F, Abi Nahed R, Brouillet S, Benharouga M and Alfaidy N
EG-VEGF maintenance over early gestation to develop a pregnancy-induced hypertensive animal model.
Methods in Molecular Biology, 2018, 1710: 317-324
Abi Nahed R, Reynaud D, Traboulsi W, Ndagijimana S, Dieudonné MN, Hoffmann P, Benharouga M and Alfaidy N
NLRP7 inflammasome is activated in FGR pregnancies: Physiological and physio-pathological implications.
Placenta, 2017, 57(Supplement C): 287
Traboulsi W, Sergent F, Boufettal H, Brouillet S, Slim R, Hoffmann P, Benlahfid M, Zhou QY, Balboni G, Onnis V, Bolze PA, Salomon A, Sauthier P, Mallet F, Aboussaouira T, Feige JJ, Benharouga M and Alfaidy N
Antagonism of EG-VEGF receptors as targeted therapy for Choriocarcinoma progression in vitro and in vivo.
Clinical Cancer Research, 2017, 23(22): 7130-7140
Sergent F, Hoffmann P, Brouillet S, Garnier V, Salomon A, Murthi P, Benharouga M, Feige JJ and Alfaidy N
Sustained endocrine gland-derived vascular endothelial growth factor levels beyond the first trimester of pregnancy display phenotypic and functional changes associated with the pathogenesis of pregnancy-induced hypertension.
Hypertension, 2016, 68(1): 148-156
Chauvet S, Boonen M, Chevallet M, Jarvis L, Abebe A, Benharouga M, Faller P, Jadot M and Bouron A
The Na+/K+-ATPase and the amyloid-beta peptide aβ1-40 control the cellular distribution, abundance and activity of TRPC6 channels.
Biochimica et Biophysica Acta - Molecular Cell Research, 2015, 1853(11): 2957-2965
Chauvet S, Traboulsi W, Thevenon L, Kouadri A, Feige JJ, Camara B, Alfaidy N and Benharouga M
EG-VEGF, BV8 and their receptors expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508).
American Journal of Physiology. Lung Cellular and Molecular Physiology, 2015, 309(3): L314-L322
Garnier V, Traboulsi W, Salomon A, Brouillet S, Fournier T, Winkler C, Desvergne B, Hoffmann P, Zhou QY, Congiu C, Onnis V, Benharouga M, Feige JJ and Alfaidy N
PPARgammacontrols pregnancy outcome through activation of EG-VEGF: New insights into the mechanism of placental development.
American Journal of Physiology. Endocrinology and Metabolism, 2015, 309(4): E357-E369
Micoud J, Chauvet S, Ludwig Scheckenbach KE, Alfaidy N, Chanson M and Benharouga M
Involvement of the heterodimeric interface region of the nucleotide binding domain-2 (NBD2) in the CFTR quaternary structure and membrane stability.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015, 1853(10 Pt A): 2420–2431
Murthi P, Brouillet S, Pratt A, Borg A, Kalionis B, Goffin F, Tsatsaris V, Munaut C, Feige J, Benharouga M, Fournier T and Alfaidy N
An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.
Molecular Medicine, 2015, 21: 645-656
Traboulsi W, Brouillet S, Sergent F, Boufettal H, Samouh N, Aboussaouira T, Hoffmann P, Feige JJ, Benharouga M and Alfaidy N
Prokineticins in central and peripheral control of human reproduction.
Hormone Molecular Biology and Clinical Investigation, 2015, 24(2): 73-81
Alfaidy N, Hoffmann P, Boufettal H, Samouh N, Aboussaouira T, Benharouga M, Feige JJ and Brouillet S
The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.
BioMed Research International, 2014, 2014: 451906
Dunand C, Hoffmann P, Sapin V, Blanchon L, Salomon A, Sergent F, Benharouga M, Sabra S, Guibourdenche J, Lye SJ, Feige JJ and Alfaidy N
Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition.
Biology of Reproduction, 2014, 91(3): 73
Holloway AC, Salomon A, Soares MJ, Garnier V, Raha S, Sergent F, Nicholson CJ, Feige JJ, Benharouga M and Alfaidy N
Characterization of the adverse effects of nicotine on placental development: In vivo and in vitro studies.
American Journal of Physiology. Endocrinology and Metabolism, 2014, 306(4): E443-456
Alfaidy N, Chauvet S, Andrei S, Salomon A, Saoudi Y, Richaud PR, Aude-Garcia C, Hoffmann P, Andrieux A, Moulis JM, Feige JJ and Benharouga M
Prion protein expression and functional importance in developmental angiogenesis: Role in oxidative stress and copper homeostasis.
Antioxidants and Redox Signaling, 2013, 18(4): 400-411
Boufettal H, Feige JJ, Benharouga M, Aboussaouira T, Nadifi S, Mahdaoui S, Samouh N and Alfaidy N
Rôle potentiel du facteur angiogénique « EG-VEGF » dans les maladies gestationnelles trophoblastiques.
Pathologie Biologie, 2013, 61(5): 178-183
Faure C, Hoffmann P, Salomon A, Garnier V, Sapin V, Blanchon L, Guibourdenche J, Benharouga M, Feige JJ and Alfaidy N
Membranes fœtales humaines, nouvelles sources et cibles du facteur endocrine EG-VEGF : implications physiologiques et physiopathologiques.
Annales d'Endocrinologie, 2013, 74(4): 312
Holloway A, Salomon A, Raha S, Granier V, Sergent MF, Nicholson CJ, Feige JJ, Benharouga M and Alfaidy N
Effet de l’exposition à la nicotine sur le développement placentaire : étude in vivo et in vitro.
Annales d'Endocrinologie, 2013, 74(4): 262-263
Brouillet S, Hoffmann P, Chauvet S, Salomon A, Chamboredon S, Sergent F, Benharouga M, Feige JJ and Alfaidy N
Revisiting the role of hCG: New regulation of the angiogenic factor EG-VEGF and of its receptors.
Cellular and Molecular Life Sciences, 2012, 69(9): 1537-1550
Hoffmann P, Brouillet S, Benharouga M, Feige JJ and Alfaidy N
Role of EG-VEGF in human placentation: Physiological and pathological implications In Recent Advances In Research on The Human Placent, édité par Zheng J, InTech, 2012, Chap 14, pp 287-306
Brouillet S, Hoffmann P, Benharouga M, Salomon A, Schaal JP, Feige JJ and Alfaidy N
Molecular characterization of EG-VEGF-mediated angiogenesis: Differential effects on microvascular and macrovascular endothelial Cells.
Molecular Biology of the Cell, 2010, 21(16): 2832-2843
Brouillet S, Hoffmann P, Benharouga M, Feige JJ and Alfaidy N
EG-VEGF is a new angiogenic factor in human placenta: Effects on micro and macrovascular endothelial cells.
Reproductive Sciences, 2009, 16: 2
Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ and Alfaidy N
Role of EG-VEGF in human placentation: Physiological and pathological implications.
Journal of Cellular and Molecular Medicine, 2009, 13(8b): 2224-2235
De Keukeleire B, Micoud J, Biard J and Benharouga M
Endoplasmic reticulum-associated degradation of mutant CFTR requires a guanine nucleotide-sensitive step.
The International Journal of Biochemistry and Cell Biology, 2008, 40(9): 1729-1742
De Keukeleire B, Donadio S, Micoud J, Lechardeur D and Benharouga M
Human cellular prion protein hPrP(C) is sorted to the apical membrane of epithelial cells.
Biochemical and Biophysical Research Communications, 2007, 354(4): 949-954
Donadio S, Alfaidy N, De Keukeleire B, Micoud J, Feige JJ, Challis JR and Benharouga M
Expression and localization of cellular prion and COMMD1 proteins in human placenta throughout pregnancy.
Placenta, 2007, 28(8-9): 907-911
Sharma M, Pampinella F, Nemes C, Benharouga M, So J, Du K, Bache KG, Papsin B, Zerangue N, Stenmark H and Lukacs GL
Misfolding diverts CFTR from recycling to degradation: Quality control at early endosomes.
Journal of Cellular Biology, 2004, 164: 923-933
Benharouga M, Sharma M, So J, Haardt M, Drzymala L, Popov M, Schwapach B, Grinstein S, Du K and Lukacs GL
The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia.
Journal of Biological Chemistry, 2003, 278(24): 22079-22089
Benharouga M, Sharma M and Lukacs GL
CFTR folding and maturation in cells.
Methods in Molecular Medicine, 2002, 70: 229-243
Benharouga M, Haardt M, Kartner N and Lukacs GL
COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.
Journal of Cellular Biology, 2001, 153: 957-70
Sharma M, Benharouga M, Hu W and Lukacs GL
Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments.
Journal of Biological Chemistry, 2001, 276: 8942-50
Top page